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Abstract
Background: Prior research reports inverse associations between maternal
prenatal urinary phthalate metabolite concentrations and mental and motor
development in preschoolers. No study evaluated whether these associations
persist into school age.
Methods: In a follow up of 328 inner-city mothers and their children, we measured
prenatal urinary metabolites of di-n-butyl phthalate (DnBP), butylbenzyl phthalate
(BBzP), di-isobutyl phthalate (DiBP), di-2-ethylhexyl phthalate and diethyl phthalate
in late pregnancy. The Wechsler Intelligence Scale for Children, 4th edition was
administered at child age 7 years and evaluates four areas of cognitive function
associated with overall intelligence quotient (IQ).
Results: Child full-scale IQ was inversely associated with prenatal urinary
metabolite concentrations of DnBP and DiBP: b522.69 (95% confidence interval
[CI]524.33, 21.05) and b522.69 (95% CI524.22, 21.16) per log unit increase.
Among children of mothers with the highest versus lowest quartile DnBP and DiBP
metabolite concentrations, IQ was 6.7 (95% CI51.9, 11.4) and 7.6 (95% CI53.2,
12.1) points lower, respectively. Associations were unchanged after control for
cognition at age 3 years. Significant inverse associations were also seen between
maternal prenatal metabolite concentrations of DnBP and DiBP and child
processing speed, perceptual reasoning and working memory; DiBP and child
verbal comprehension; and BBzP and child perceptual reasoning.
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Conclusion: Maternal prenatal urinary metabolite concentrations measured in late
pregnancy of DnBP and DiBP are associated with deficits in children’s intellectual
development at age 7 years. Because phthalate exposures are ubiquitous and
concentrations seen here within the range previously observed among general
populations, results are of public health significance.
Introduction
Phthalates are a class of high production chemicals widely used as plasticizers and
additives in consumer and personal care products [1]. Many phthalates are
endocrine disruptors which may operate through multiple mechanisms including
perturbations in thyroid hormone and testosterone levels [2, 3]. Exposures to
phthalates are ubiquitous [4, 5]. Urinary concentrations of phthalate metabolites
are used as internal dosimeters because urinary enzymatic activity is negligible [6];
thus metabolite concentrations in urine reflect an individual’s internal exposure to
phthalates, rather than phthalate contaminants introduced during sample
collection and processing. Prior studies have shown moderate reproducibility (i.e.
intraclass correlation coefficients ranging from approximately 0.20 to 0.77) for
measurements of several phthalate metabolite concentrations in repeat spot urine
samples [5, 7–9].
Limited epidemiologic studies have reported inverse associations between
phthalate metabolites in maternal prenatal urine and child mental, motor and
behavioral development [5, 10]. Previously, we reported that maternal prenatal
urinary concentrations of mono-n-butyl phthalate (MnBP) and monoisobutyl
phthalate (MiBP), the main metabolites of di-n-butyl phthalate (DnBP) and di-
isobutyl phthalate (DiBP), respectively, were inversely associated with child age 3
year motor development and increased the risk of motor delay [5]. Among girls,
MiBP was also inversely associated with mental development [5]. Experimental
animal studies find inverse associations between prenatal exposure to di-2-
ethylhexyl phthalate (DEHP) and DnBP and learning and memory in the
offspring [11, 12]. No prior studies have evaluated associations between prenatal
phthalate exposures on child intelligence quotient (IQ) in school-age children.
However, a cross-sectional study of Korean 3rd and 4th grade children found
inverse associations between DEHP metabolites in child urine and IQ [13]. Based
on these findings, we hypothesized that prenatal phthalates exposures would be
inversely associated with child IQ at age 7 years.
Methods
We studied 328 inner-city women and their 7-year old children from the
Columbia Center for Children’s Environmental Health (CCCEH) longitudinal
birth cohort of 727 pregnant women who delivered between 1998 and 2006. The
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original aim of the cohort was to examine the associations between exposure to air
pollutants and pregnancy outcomes and child development. Enrollment,
exclusion criteria, and a description of the cohort have been described previously
[14]. Women 18–35 years old who self-identified as either African American or
Dominican were enrolled through prenatal clinics associated with Harlem and
New York Presbyterian Hospitals. Women were excluded if they reported active
smoking, use of other tobacco products or illicit drugs, had diabetes, hypertension
or known HIV, had their first prenatal visit after the 20th week of gestation or had
resided in the study area for less than one year prior to pregnancy. Mother-child
pairs were selected for participation in the current study if phthalate metabolite
concentrations had been measured in spot urine samples collected during
pregnancy and if the child had completed the Wechsler Intelligence Scale for
Children, 4th edition (WISC-IV) at age 7 years. We excluded women with active
smoking during pregnancy verified by maternal and/or umbilical cord plasma
cotinine .15 ng/ml at delivery (n530), no or insufficient urine for measurement
of phthalate metabolites (n5286), and those lost to follow-up prior to child age 7
years (n583). Among women who had prenatal phthalate measurements, the
retention rate was 80% at the 7-year follow-up. The 328 study subjects did not
differ significantly from the remaining subjects in the CCCEH cohort in terms of
demographics (race/ethnicity, maternal marital status, education level, household
income, proportion receiving Medicaid), prenatal alcohol consumption, child sex,
gestational age, and birth weight (all p-values.0.05). Moreover, study children
did not differ from the remaining children with respect to mental and motor
development scores at age 3 years.
Ethics Statement
Institutional review boards at the Columbia University Medical Center and the
Centers for Disease Control and Prevention (CDC) approved the study and all
consent procedures for the study. Written informed consent was obtained from all
participating mothers, who also provided written informed consent on behalf of
their children, and written informed assent was obtained from all children starting
at age 7 years.
Urine sample collection and phthalate measurements
Spot urine samples were collected during the 3rd trimester of pregnancy (average
34.0¡3.0 weeks, median 33.9) and from the children at ages 3 (n5241) and 5
(n5277) years. Samples were analyzed for metabolites of 5 phthalates (DnBP,
BBzP, DiBP, DEHP and diethylphthalate) at the CDC as described [15]. Specific
gravity was measured in the urine samples using a handheld refractometer and
used to control for urinary dilution (Atago PAL 10-S, Bellevue, WA) [7].
As a measure of reliability, we calculated intraclass correlation coefficients
(ICCs) for the phthalate metabolites in serial spot urine samples collected
biweekly from 48 women in the CCCEH cohort over 6–8 weeks late in pregnancy
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(n5135 samples, 2–4 repeats per woman). Adjusting for specific gravity, ICCs
were 0.77 for MBzP, 0.65 for mono-n-butyl phthalate (MnBP), and 0.60 for
monoisobutyl phthalate (MiBP) and ranged from 0.27 to 0.42 for the DEHP
metabolites [5].
Measures of child mental development
The Wechsler Intelligence Scale for Children, 4th edition (WISC-IV) [16] was
administered to children at age 7 years. The instrument measures four areas of
mental functioning that are associated with, but distinct from, overall IQ. The
Verbal Comprehension Index is a measure of verbal concept formation; the
Perceptual Reasoning Index measures nonverbal and fluid reasoning; the Working
Memory Index assesses children’s ability to memorize new information, hold it in
short-term memory, concentrate, and manipulate information; and the
Processing Speed Index assesses ability to focus attention and quickly scan,
discriminate, and sequentially order visual information. Full-Scale IQ score
combines the four composite indices. All WISC-IV scales are standardized to a
mean of 100 and standard deviation (SD) of 15. The WISC-IV has been shown in
prior research to be sensitive to effects of low-dose neurotoxicant exposures on
cognition [17–19].
Model covariates
Information on potential confounders was gathered by questionnaires adminis-
tered to the mother during pregnancy and at various postnatal intervals by trained
bi-lingual interviewers and by review of maternal and infant medical records.
Variables of interest included race/ethnicity, maternal education and marital
status, household income, parity, gestational age, birth weight, child sex,
breastfeeding history, exposure to tobacco smoke in the home, prenatal alcohol
consumption, and prenatal psychosocial factors including maternal self-report of
hardship during pregnancy (i.e., lack of food, clothing, housing, gas or electricity,
or medicines) and satisfaction with overall living conditions. Maternal
demoralization was measured by the 27-item Psychiatric Epidemiology Research
Instrument-Demoralization Scale [20]. Maternal intelligence was assessed by the
Test of Non-Verbal Intelligence, third edition [21], a language-free measure of
general intelligence, which is relatively stable and free of cultural bias. The quality
of the care-taking environment was measured by the Home Observation for
Measurement of the Environment (HOME) scale [22] at child age 38.4¡6.2
months.
Statistical analysis
Linear regression models were used to examine relationships between prenatal
exposures to the five phthalates (assessed from the urinary metabolite
concentrations) and WISC-IV outcomes. Phthalate metabolite concentrations
below the limit of detection (LOD) (one for monobenzyl phthalate (MBzP), one
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for mono-isobutyl phthalate (MiBP) and 53 for mono-2-ethylhexyl phthalate
(MEHP)) were assigned a value of LOD/!2 [23]. The distributions of the
phthalate metabolite concentrations were right skewed and transformed using the
natural logarithm to improve model fitting and reduce the influence of extreme
values. In our analyses, each metabolite was considered as a continuous variable
and was categorized into quartiles to explore the shape of the dose response
relationship. The final regression models included covariates that were a priori
potential confounders based on previous literature and a directed acyclic graph,
and that were associated with at least one WISC-IV subscale or the total WISC-IV
score [5, 17, 18]. Missing values for covariates were imputed as follows: a) twelve
missing values for maternal IQ were imputed by a linear regression model with
race/ethnicity, maternal education and age as predictors (model R250.13); b)
twenty missing observations for the HOME scale were imputed by linear
regression model with race/ethnicity, maternal education and IQ, and household
income as predictors (model R250.18); c) ten missing observations for prenatal
maternal alcohol consumption were given a category of missing. Sensitivity
analyses were conducted for observations with no missing data (reducing the
sample size to 290); results were essentially unchanged from those reported here.
We used maternal urinary concentrations of mono-2-ethyl-5-hydroxyhexyl
phthalate (MEHHP) as the proxy for exposure to DEHP. All DEHP metabolites
were highly correlated with each other (Spearman correlation coefficient r$0.8)
[25]. In a sensitivity analysis results using MEHP as the DEHP exposure proxy
were essentially the same. Analyses were repeated using the molar sum of all four
DEHP metabolites, also with essentially the same results. Urinary specific gravity
was included in all models to control for dilution 7. We evaluated confounding in
two ways. First, we constructed a directed acyclic graph to determine potential
confounders. Second, for each potential confounder, we assessed the change in the
estimated regression coefficient between the exposure of interest (i.e. specific
phthalate metabolite) and outcome (i.e. either the WISC IQ measure or the WISC
subscale measure) with and without the potential confounder. We included
variables in the model if their inclusion changed the estimated regression
coefficient between exposure and outcome by more than.5 standard deviation
units. To evaluate whether sex of the child was an effect modifier, we conducted
analyses separately by sex, and assessed whether the estimated coefficients differed
using the Wald test. In secondary analyses, we included a measure of cognitive
performance at age 3 years (the Mental Development Index (MDI) from the
Bayley Scales of Infant Development-second edition (1993). Additionally, we
evaluated whether child age 3 and 5 years urinary phthalate metabolite
concentrations were associated with WISC-IV outcomes at age 7 years. We also
evaluated whether other contaminants, namely lead, chlorpyrifos, and polycyclic
aromatic hydrocarbons (PAHs), were potential confounders. With the exception
of a negative correlation between PAHs and one phthalate metabolite (MiBP)
(r520.13, p5.02), no correlations were found between any other contaminant
and phthalate metabolite. In a sensitivity analysis, we included PAHs in the
regression model relating MiBP to the cognitive outcomes; the magnitudes of the
Prenatal Phthalates and Child IQ
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regression coefficients became stronger and more statistically significant. Analyses
were conducted using SAS (version 9.3 SAS Institute Inc., Cary, NC).
Results
Maternal sociodemographic characteristics, infant birth and child characteristics
and distributions of model covariates and outcome variables are presented in
Table 1. Eighteen children (5.5%) were administered the test in Spanish. Table 2
shows the distribution of the urinary phthalate metabolite concentrations in
maternal prenatal spot samples. Metabolites were detected in 99.7–100% of the
samples, except for MEHP in which 16% of the measures were below the LOD.
Nevertheless, for the 53 measures that were below the LOD, using the actual
concentrations or the assignment of a value (1/!2)6LOD produced essentially the
same results. Spearman correlation coefficients between the specific gravity
adjusted maternal prenatal metabolite concentrations ranged from 0.15 (for
monoethyl phthalate (MEP) and both MBzP and MEHHP) to 0.63 (for MiBP and
MnBP). Correlations for the urinary phthalate metabolite concentrations in child
age 3 and 5 year samples were similar (data not shown). However, correlations
between each phthalate metabolite across ages (prenatal, age 3 and 5 years) were
not statistically significant. The correlation between Bayley MDI score and full
scale IQ at age 7 was 0.43 (p,.0001) and between maternal IQ and full scale IQ at
age 7 was 0.26 (p,.0001).
In the total cohort (table 3), full scale IQ was inversely associated with
logeMnBP (b5–2.69 [95% CI5–4.33, –1.05]) and logeMiBP (b5–2.69 [95%
CI5–4.22, –1.16]) but not with the other phthalate metabolites. Additonally,
logeMnBP, logeMiBP and logeMBzP were significantly inversely associated with
perceptual reasoning, logeMnBP and logeMiBP with processing speed, logeMiBP
with verbal comprehension, and logeMnBP and logeMiBP with working memory.
There were no significant associations between maternal MEHP, MEHHP or MEP
concentrations and any of the WISC-IV scales. There were some differences in the
estimated regression coefficients relating the exposures to outcomes between boys
and girls, although with one exception none reached statistical significance.
Specifically, associations between MnBP and full scale IQ and perceptual
reasoning appeared stronger among girls than boys, and associations between
MnBP and processing speed appeared stronger among boys. Additionally,
associations between MBzP and perceptual reasoning and between MiBP and
verbal comprehension appeared stronger among boys. MnBP was associated with
working memory and the size of the associations was significantly larger among
girls than boys (p50.02 Wald test). Controlling for postnatal year three and year
five phthalate metabolites concentrations did not alter the association between
prenatal phthalate exposures and the WISC outcomes at age 7 years.
Full scale IQ scores among children born to mothers with urinary MnBP and
MiBP concentrations in the highest compared to the lowest quartiles were 6.6,
95% CI5(1.89, 11.41) and 7.6, 95% CI5(3.2, 12.1) points lower, respectively
Prenatal Phthalates and Child IQ
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(Figure 1). Similar differences were found for the perceptual reasoning, processing
speed and working memory scores. Children whose mother had the highest versus
lowest concentration of MBzP and MiBP had significantly lower scores on
Table 1. Subject demographics, distribution of model covariates, and outcome variables (N5328).
Characteristic Value (%)
Maternal age at prenatal interview (yr) 25.3¡4.8
Ethnicity
African American 215 (34.5)
Dominican or other Hispanic 113 (65.5)
Maternal education
,High school degree 119 (36.3)
$High school diploma or general educational development (GED) 209 (63.7)
Marital status
Never married 220 (67.1)
Ever Marrieda 108 (32.9)
Maternal IQ (n5316) 84.6¡13.3
HOME scale (n5308) 39.2¡6.3




Child age at WISC-IV (yr) 7.05¡0.20
WISC-IV Outcome variables
Full Scale Composite Score 97.1¡13.1
Perceptual Reasoning Composite Score 99.3¡14.0
Processing Speed Composite Score 98.9¡14.6
Verbal Comprehension Composite Score 94.4¡12.7
Working Memory Composite Score 98.5¡14.9
Values are mean ¡ SD or n (percent). Unless indicated, N5328.
aIncludes living with same partner for .7 years.
doi:10.1371/journal.pone.0114003.t001
Table 2. Distribution of Phthalate metabolites (ng/ml) in maternal spot urine during the third trimester of pregnancy (n5328).
Metabolite Mean 95% CI LOD* %,LOD Range 25% Median 75%
MnBP 37.6 (33.5, 42.3) 0.6 0 1.2–1,110 19.4 38.0 79.8
MBzP 13.4 (11.6, 15.4) 0.22 0.3 ND–550.4 5.8 14.4 30.0
MEHHP 22.3 (19.4, 25.5) 0.7 0 1.1–1750 10.6 21.8 47.2
MEHP 4.95 (4.2, 5.7) 1.2 16.2 ND–613 1.9 4.9 12.4
MEP 160.5 (140.4, 183.4) 0.53 0 7.8–6045.6 69.9 141.5 334.1
MiBP 9.1 (8.1. 10.2) 0.3 0.3 ND–374.4 5.0 9.2 19.0
ND5not detected.
doi:10.1371/journal.pone.0114003.t002
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Table 3. Estimated adjusted regression coefficients relating maternal prenatal urinary phthalate concentrations to the WISC-IV full scale IQ and subscales at
child age 7 years.
B-Coefficient (95% CI) Child sex
Total Girls Boys Difference
Metabolite (log base e) (n5328) (n5173) (n5155) p-value@
Full Scale
MBnP 22.69 (24.33,21.05)** 23.15 (25.44,20.87)** 21.89 (24.34, 0.56) 0.46
MBzP 21.18 (22.40, 0.05) 20.84 (22.52, 0.83) 21.48 (23.35, 0.38) 0.61
MEHHP 0.16 (21.16, 1.48) 0.34 (21.35, 2.03) 0.26 (21.87, 2.40) 0.96
MEHP 20.30 (21.42, 0.82) 20.05 (21.53, 1.42) 0.09 (21.92, 2.11) 0.74
MEP 20.17 (21.46, 1.13) 20.75 (22.53, 1.03) 0.40 (21.53, 2.33) 0.39
MiBP 22.69 (24.22,21.16)** 22.38 (24.50,20.26)* 22.92 (25.17,20.67)* 0.73
Perceptual Reasoning
MnBP 22.58 (24.40,20.76)** 23.55 (25.96,21.14)** 21.50 (24.36, 1.35) 0.28
MBzP 21.65 (23.00,20.30)* 21.13 (22.89, 0.64) 22.45 (24.60,20.31)* 0.35
MEHHP 0.18 (21.28, 1.64) 0.03 (21.76, 1.82) 0.56 (21.92, 3.04) 0.73
MEHP 20.07 (21.30, 1.17) 20.09 (21.65, 1.48) 0.01 (22.00, 2.03) 0.94
MEP 20.62 (22.05, 0.81) 20.67 (22.56, 1.22) 20.57 (22.81, 1.67) 0.95
MiBP 22.41 (24.11,20.71)* 22.39 (24.64,20.14)* 22.41 (25.05, 0.23) 0.99
Processing Speed
MnBP 22.01 (23.91,20.11)* 21.29 (24.04, 1.45) 22.85 (25.63,20.08)* 0.43
MBzP 20.47 (21.88, 0.95) 20.74 (22.72, 1.23) 20.02 (22.17, 2.12) 0.63
MEHHP 20.41 (21.91, 1.10) 20.84 (22.83, 1.15) 0.25 (22.19, 2.68) 0.50
MEHP 20.95 (22.23, 0.33) 20.93 (22.67, 0.80) 20.94 (22.92, 1.03) 0.99
MEP 0.54 (20.95, 2.03) 20.26 (22.37, 1.84) 1.21 (20.99, 3.41) 0.34
MiBP 21.94 (23.72,20.17)* 21.94 (24.46, 0.58) 22.10 (24.70, 0.50) 0.93
Verbal Comprehensionn
oCnsion
MnBP 21.52 (23.06, 0.02) 21.06 (23.29, 1.16) 21.64 (23.90, 0.62) 0.72
MBzP 20.78 (21.92, 0.36) 20.46 (22.06, 1.14) 21.07 (22.79, 0.66) 0.61
MEHHP 0.46 (20.76, 1.69) 0.86 (20.75, 2.47) 0.09 (21.88, 2.06) 0.55
MEHP 20.28 (21.32, 0.76) 20.01 (21.42, 1.40) 20.60 (22.20, 1.00) 0.58
MEP 0.10 (21.30, 1.11) 20.71 (22.42, 0.99) 0.52 (21.26, 2.31) 0.32
MiBP 22.08 (23.51,20.65)** 21.05 (23.10, 1.00) 23.04 (25.11,20.98)** 0.18
Working Memory
MnBP 22.57 (24.55,20.59)** 24.73 (27.53,21.93)** 20.07 (22.92, 2.78) 0.02
MBzP 20.68 (22.16, 0.80) 20.59 (22.67, 1.48) 20.50 (22.68, 1.67) 0.95
MEHHP 0.36 (21.23, 1.94) 1.16 (20.92, 3.25) 20.29 (22.76, 2.18) 0.37
MEHP 0.55 (20.79, 1.89) 1.22 (20.60, 3.04) 0.09 (21.92, 2.11) 0.41
MEP 20.39 (21.95, 1.17) 21.06 (23.26, 1.15) 0.28 (21.96, 2.52) 0.40
MiBP 21.98 (23.84,20.12)* 22.53 (25.16, 0.11) 21.27 (23.92, 1.38) 0.51
*p,0.05, **p#0.01. @Wald Test.
Adjusted model for specific gravity, maternal IQ, ethnicity, alcohol use during pregnancy, education, marital status, total home score, and sex of child.
doi:10.1371/journal.pone.0114003.t003
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perceptual reasoning (by 3.9 points) and verbal comprehension (by 4.4 points),
respectively.
Examination of postnatal phthalate exposure controlling for prenatal exposure
suggested specific associations between MBzP measured at age 3 and several of the
outcomes. Specifically, we found inverse associations between, loge MBzP
concentrations measured at age 3 were inversely associated with full-scale IQ
(b5–1.52; 95% CI5(–2.71, –0.32)), perceptual reasoning (b5–1.68; 95% CI5(–
3.01, –0.36)), and working memory (b5–2.2.47; 95% CI5(–3.92, –1.01)) at age 7
years (see Table S1). We observed no associations between concentrations of
phthalate metabolites measured at age 5 years and IQ measured at age 7 years; nor
did we see any significant associations between the WISC-IV scales and MnBP and
MiBP measured at age 3 years. Finally, there was no change in the associations
between prenatal urinary phthalate metabolites and any of the WISC outcomes
after inclusion of the child age 3 years mental development index (MDI) on the
Figure 1. Adjusted mean WISC-IV total score and subtest scored by lowest to highest quartile of
maternal prenatal phthalate metabolite concentration (where q05lowest quartile, q45highest quartile,
q2 and q3 intermediate quartiles). Means adjusted for urine specific gravity, maternal IQ, ethnicity, alcohol
use during pregnancy, education, marital status, quality of the home environment (HOME score) and sex of
child. *p,0.05, **p#0.01.
doi:10.1371/journal.pone.0114003.g001
Prenatal Phthalates and Child IQ
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Bayley Scales of Infant Development. Associations also did not change when
language of test administration was controlled.
Discussion
In our follow up study of children prenatally exposed to phthalates, we found
significant associations between exposure to DnBP and DiBP and IQ measured at
age 7 years, after adjusting for potential confounders. Compared to children born
to women in the lowest 25th concentration percentile, children born to women
above the 75th concentration percentile for MnBP and MiBP scored 6.6 and 7.6
points lower on 7 year IQ. Similar associations were found between these
metabolites and perceptual reasoning, working memory and processing speed
subscales of the WISC-IV. Differences in the estimates of association were found
in boys and girls. Associations between maternal prenatal MnBP concentrations
and child age 7 full scale IQ, perceptual reasoning and working memory were
stronger among girls and associations between maternal prenatal MnBP and
MiBP concentrations and processing speed and verbal comprehension, respec-
tively, were stronger among boys. We note however, that with one exception the
interactions between phthalate metabolites and sex did not reach conventional
statistical significance criterions.
These findings extend our earlier observation of associations between prenatal
exposure to phthalates and children’s cognitive function and behavior at age 3
years5. In the earlier analysis, we found inverse associations between urinary
concentrations of MnBP and MiBP and scores on the psychomotor development
index (PDI) of the Bayley Scales of Infant Development (BSID) for both boys and
girls, and an inverse association between MnBP concentrations and the mental
development index (MDI) of the BSID in girls only. Taken together, our findings
suggest adverse associations between prenatal phthalate exposure and cognition
that persist into the early school years, with potentially meaningful implications
for academic performance. We also find associations between MBzP measured at
age 3 and full scale IQ, and the perceptual motor and working memory subscales
at age 7, suggesting a role of postnatal exposure for specific phthalates.
Several studies have reported associations between prenatal phthalate exposure
and neurodevelopment, but the literature is inconsistent regarding the specific
phthalate metabolites examined and the finding of sex-specific associations. Engel,
et al (2009) [24] found associations in girls, but not boys, between metabolites of
high molecular weight phthalates (e.g. DEHP, BBzP) on the Brazelton Neonatal
Behavioral Scale administered within five days of delivery. Yolton, et al (2011)
[25] reported associations between the urinary concentrations of DEHP
metabolites and suboptimal neurological reflexes in boys at 5 weeks of age. Kim, et
al (2011) [10] found associations between urinary concentrations of DEHP
metabolites and delays in both BSID mental and motor development and urinary
concentrations of DnBP metabolite and delays in mental development in 6-month
old Korean boys. These three studies are limited by the measure of
Prenatal Phthalates and Child IQ
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neurobehavioral assessment, which becomes more reliable as the children age.
Tellez-Rojo et al (2013) [26] evaluated prenatal phthalate exposure and repeated
BSID scores at ages 2, 2.5 and 3 years in 135 children enrolled in the ELEMENT
study in Mexico and found associations with DEHP metabolites in sex-specific
analyses only. A final, albeit cross sectional, study found inverse associations
between metabolites of DEHP and DnBP and vocabulary development at ages 8–
11 years among Korean children [13]. The inconsistent associations regarding the
specific phthalates may be due to the variability in age of assessment (the BSID
become more stable with increasing age at assessment), the WISC testing different
constructs than the BSID, poor adjustment for the correlations between phthalate
metabolites, and differences in the concentrations of phthalates in the specific
populations. Nevertheless, the consistent pattern of associations between MnBP
and MiBP across ages in our cohort lends support to our cognitive findings.
Comparison of the concentrations of phthalate metabolites in our study to
those in the last reported NHANES data [27] find, as expected, slightly higher
concentrations among women in our sample. However, the confidence intervals
in our data and the NHANES data overlap substantially, suggesting that the
concentrations in our study are still relevant.
There are several possible mechanisms underlying these associations. Phthalates
may act as anti-androgens and lead to disruption in the normal sexual
differentiation of the brain [28–30]; they may modulate the activity of aromatase
in the developing brain and thus interfere with estrogen synthesis [31, 32]; they
may interfere with thyroid hormone production [33–36, 29, 37–41]; and they may
disrupt brain dopaminergic activity [42, 43] which is linked to inattention and
hyperactivity [44]. These mechanisms may shed light on why the adverse
associations are sex specific.
Our study has a number of strengths. First it is a prospective evaluation with
assessment of exposure to phthalates not only in the prenatal period, but also at
ages 3 and 5 years. It is noteworthy that our associations were primarily limited to
prenatal concentrations of phthalate metabolites, with some additional associa-
tions seen for age 3 exposures, suggesting that there are critical periods of
exposure related to adverse cognitive outcomes. Second, although our sample size
was likely not sufficient to estimate sex-specific associations, we did observe
several sex specific differences in associations. This is important given that many
of the purported mechanisms for these associations are linked to brain
concentrations of sex hormones. However, there are also some limitations. We are
unable to identify specific times during pregnancy when phthalates could be
related to outcomes as urine was only collected from the pregnant women in the
third trimester. Because phthalates have a half- life of approximately 12 hours,
single, spot urine measures do not reflect long term exposure. We evaluated
reproducibility of these urine measures in a sample of 48 women who had repeat
urine measures during the third trimester; the ICCs were 0.77 for MBzP, 0.65 for
mono-n-butyl phthalate (MnBP), and 0.60 for monoisobutyl phthalate (MiBP)
and ranged from 0.27 to 0.42 for the DEHP metabolites, indicating moderate
reliability over a short time span. Strictly speaking, therefore, our results should be
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specific to phthalate exposure during the third trimester. Restriction of the study
sample to inner-city African American and Hispanics reduces the generalizability
of the results, but likely also minimized residual confounding by socioeconomic
status and race. We note that we also controlled for a variety of factor known to be
associated with child IQ, namely maternal IQ, race/ethnic group, alcohol use
during pregnancy, maternal education, marital status, other contaminants and
HOME score. Birth weight, another predictor of child IQ, did not change the
estimated associations between any phthalate metabolite and IQ. Further work in
other ethnic and socioeconomic populations would be needed to generalize these
results. We also measured a limited number of phthalate metabolites and thus
cannot infer our results to other phthalates. We also could not evaluate the
associations between phthalate exposure and school performance as these data are
not available. Finally, there may be some measurement error in the categorization
of phthalates exposure based on urinary metabolite concentrations because the
correlations between measures of the same metabolite over relatively short
intervals were moderate to low [9].
Given the observational nature of this study, we cannot conclude a causal
relationship between late prenatal exposure to certain phthalates and reductions
in IQ. Nevertheless, we have now observed consistent associations between
exposure and outcomes measured at two time-points, one in the preschool years
and one in the early school years, suggesting the results are not spurious and
appear to be persistent. Indeed, the associations in the early school years are not
diminished after control for MDI measured at age 3 years, suggesting a robust
association. We note that the consistency of the associations over time has
implications for public health and regulatory policy.
In conclusion, our analysis of the associations between prenatal phthalate
exposure and IQ in the early school years showed significant decrements in IQ
associated with two specific phthalates. These findings are important to inform
policy makers of the potentially harmful effects of this class of chemicals.
Supporting Information
Table S1. Estimated coefficients of urinary phthalate concentrations in the
linear model for WISC-IV when the children were 7 years of age. aModels
include those with phthalate metabolite data at age 3. bModels include those with
phthalate metabolite data at age 5. *p,0.05, **p#0.01. The model controlled for
specific gravity (prenatal, age 3, and age 5 as appropriate), maternal IQ, ethnicity,
alcohol use during pregnancy, education, marital status, total home score, and sex
of child.
doi:10.1371/journal.pone.0114003.s001 (DOCX)
Prenatal Phthalates and Child IQ
PLOS ONE | DOI:10.1371/journal.pone.0114003 December 10, 2014 12 / 15
Acknowledgments
The authors gratefully acknowledge the technical assistance of Manori Silva, Ella
Samandar, Jim Preau, and Lily Jia in measuring the urinary concentrations of
phthalate metabolites.
The findings expressed in this paper are the opinions of the authors and do not
necessarily reflect the official opinion of the Centers for Disease Control and
Prevention.
This work was supported by National Institute of Environmental Health
Sciences (NIEHS) grants R01ES013543, R01ES014393, and R01ES08977 and by
NIEHS/U.S. Environmental Protection Agency grant P50 ES09600/RD 83214101.
Author Contributions
Conceived and designed the experiments: PF-L VAR RMW. Performed the
experiments: PF-L BI AMC XL FP VAR RMW. Analyzed the data: PF-L BI XL
RMW. Contributed reagents/materials/analysis tools: AMC. Contributed to the
writing of the manuscript: PF-L BI AMC XL FP VAR RMW.
References
1. Sathyanarayana S (2008) Phthalates and children’s health. Curr Probl Pediatr Adolesc Health Care 38:
34–49.
2. Braun JM, Sathyanarayana S, Hauser R (2013) Phthalate exposure and children’s health. Current
opinion in pediatrics 25: 247–54.
3. Bellinger DC (2013). Prenatal Exposures to Environmental Chemicals and Children’s
Neurodevelopment: An Update. Saf Health Work 4: 1–11.
4. CDC. Fourth National Report on Human Exposure to Environmental Chemicals. Centers for Disease
Control and Prevention Department of Health and Human Services. Available: http://wwwcdcgov/
exposurereport Accessed 2011 February 25.
5. Whyatt RM, Liu X, Rauh VA, Calafat AM, Just AC, et al. (2012) Maternal prenatal urinary phthalate
metabolite concentrations and child mental, psychomotor, and behavioral development at 3 years of age.
Environ Health Perspect 120: 290–5.
6. Kato K, Silva MJ, Reidy JA, Hurtz D 3rd, Malek NA, et al. (2004) Mono(2-ethyl-5-hydroxyhexyl)
phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-
(2-ethylhexyl) phthalate. Environ Health Perspect 112: 327–30.
7. Hauser R, Meeker JD, Park S, Silva MJ, Calafat AM (2004) Temporal variability of urinary phthalate
metabolite levels in men of reproductive age. Environ Health Perspect 112: 1734–40.
8. Teitelbaum SL, Britton JA, Calafat AM, Ye X, Silva MJ, et al. (2008) Temporal variability in urinary
concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the
United States. Environ Res 106: 257–69.
9. Adibi JJ, Whyatt RM, Williams PL, Calafat AM, Camann D, et al. (2008) Characterization of Phthalate
Exposure among Pregnant Women Assessed by Repeat Air and Urine Samples. Environ Health
Perspect 116: 467–73.
10. Kim Y, Ha EH, Kim EJ, Park H, Ha M, et al. (2011) Prenatal exposure to phthalates and infant
development at 6 months: prospective Mothers and Children’s Environmental Health (MOCEH) study.
Environ Health Perspect 119: 1495–500.
11. Li Y, Zhuang M, Li T, Shi N (2009) Neurobehavioral toxicity study of dibutyl phthalate on rats following in
utero and lactational exposure. J Appl Toxicol 29: 603–11.
Prenatal Phthalates and Child IQ
PLOS ONE | DOI:10.1371/journal.pone.0114003 December 10, 2014 13 / 15
12. Boberg J, Christiansen S, Axelstad M, Kledal TS, Vinggaard AM, et al. (2011) Reproductive and
behavioral effects of diisononyl phthalate (DINP) in perinatally exposed rats. Reprod Toxicol 31: 200–9.
13. Cho SC1, Bhang SY, Hong YC, Shin MS, Kim BN, et al. (2010) Relationship between environmental
phthalate exposure and the intelligence of school-age children. Environ Health Perspect 118: 1027–32.
14. Perera FP, Rauh V, Tsai WY, Kinney P, Camann D, et al. (2003) Effects of transplacental exposure to
environmental pollutants on birth outcomes in a multiethnic population. Environ Health Perspect 111:
201–5.
15. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, et al. (2004) Urinary levels of seven phthalate
metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES)
1999–2000. Environ Health Perspect; 112: 331–8.
16. Wechsler D (2003) Wechsler Intelligence Scale for Children, 4th edition. San Antonio, TX: Psychological
Corporation.
17. Rauh V, Arunajadai S, Horton M, Perera F, Hoepner L, et al. (2011) Seven-year neurodevelopmental
scores and prenatal exposure to chlorpyrifos, a common agricultural pesticide. Environ Health Perspect
119: 1196–201.
18. Bouchard MF, Chevrier J, Harley KG, Kogut K, Vedar M, et al. (2011) Prenatal exposure to
organophosphate pesticides and IQ in 7-year-old children. Environ Health Perspect 119: 1189–95.
19. Jusko TA, Henderson CR, Lanphear BP, Cory-Slechta DA, Parsons PJ, et al. (2008) Blood lead
concentrations ,10 microg/dL and child intelligence at 6 years of age. Environ Health Perspect 116:
243–8.
20. Dohrenwend BS, Krasnoff L, Askenasy AR, Dohrenwend BP (1978) Exemplification of a method for
scaling life events: the Peri Life Events Scale. J Health Soc Behav 19: 205–29.
21. Brown L, Sherbenou RJ, Johnson SK (1990) Test of Non-verbal Intelligence: A language-Free
Measure of Cognitive Ability. Austin, TX: PRO-ED.
22. Caldwell BM, Bradley RH (1979) Home observation for measurement of the environment. Little Rock:
University of Arkansas Press.
23. Hornung RW, Reed DL (1990) Estimation of average concentration in the presence of nondetectable
values. Appl Occup Environ Hyg 5: 46–51.
24. Engel SM, Zhu C, Berkowitz GS, Calafat AM, Silva MJ, et al. (2009) Prenatal phthalate exposure and
performance on the Neonatal Behavioral Assessment Scale in a multiethnic birth cohort.
Neurotoxicology 30: 522–8.
25. Yolton K, Xu Y, Strauss D, Altaye M, Calafat AM, et al. (2011) Prenatal exposure to bisphenol A and
phthalates and infant neurobehavior. Neurotoxicol Teratol 33: 558–66.
26. Te´llez-Rojo MM, Cantoral A, Cantonwine DE, Schnaas L, Peterson K, et al. (2013) Prenatal urinary
phthalate metabolites levels and neurodevelopment in children at two and three years of age. Sci Total
Environ 461–462: 386–90.
27. Zota AR, Calafat AM, Woodruff TJ (2014) Temporal trends in phthalate exposures: Findings from the
National Health and Nutrition Examination Survey, 2001–2010. Environ Health Perspect 122: 235–41.
28. Weiss B (2012) The intersection of neurotoxicology and endocrine disruption. Neurotoxicology 33:
1410–1419.
29. Wolstenholme JT, Rissman EF, Connelly JJ (2011) The role of Bisphenol A in shaping the brain,
epigenome and behavior. Horm Behav 59: 296–305.
30. Howdeshell KL, Wilson VS, Furr J, Lambright CR, Rider CV, et al. (2008) A mixture of five phthalate
esters inhibits fetal testicular testosterone production in the Sprague Dawley rat in a cummulative, dose
additive manner. Toxicological Sciences 105: 153–165.
31. Andrade AJ, Grande SW, Talsness CE, Grote K, Chahoud I (2006) A dose-response study following
in utero and lactational exposure to di-(2-ethylhexyl)-phthalate (DEHP): non-monotonic dose-response
and low dose effects on rat brain aromatase activity. Toxicology 227: 185–192.
32. Bonefeld-Jorgensen EC, Long M, Hofmeister MV, Vinggaard AM (2007) Endocrine-disrupting
potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new
data and a brief review. Environ Health Perspect 115 Suppl 1:: 69–76.
Prenatal Phthalates and Child IQ
PLOS ONE | DOI:10.1371/journal.pone.0114003 December 10, 2014 14 / 15
33. Breous E, Wenzel A, Loos U (2005) The promoter of the human sodium/iodide symporter responds to
certain phthalate plasticisers. Mol Cell Endocrinol 244: 75–78.
34. Hinton RH, Mitchell FE, Mann A, Chescoe D, Price SC, et al. (1986) Effects of phthalic acid esters on
the liver and thyroid. Environ Health Perspect 70: 195–210.
35. Howarth JA, Price SC, Dobrota M, Kentish PA, Hinton RH (2001) Effects on male rats of di-(2-
ethylhexyl) phthalate and di-n-hexylphthalate administered alone or in combination. Toxicol Lett 121: 35–
43.
36. O’Connor JC, Frame SR, Ladics GS (2002) Evaluation of a 15-day screening assay using intact male
rats for identifying steroid biosynthesis inhibitors and thyroid modulators. Toxicol Sci 69: 79–91.
37. Sugiyama S, Shimada N, Miyoshi H, Yamauchi K (2005) Detection of thyroid system-disrupting
chemicals using in vitro and in vivo screening assays in Xenopus laevis. Toxicol Sci 88: 367–374.
38. Boas M, Frederiksen H, Feldt-Rasmussen UF, Skakkebaek NE, Hegedus L, et al. (2010) Childhood
exposure to phthalates: association with thyroid function, insulin-like growth factor I, and growth. Environ
Health Perspect 118: 1458–1464.
39. Meeker JD, Calafat AM, Hauser R (2007) Di(2-ethylhexyl) phthalate metabolites may alter thyroid
hormone levels in men. Environ Health Perspect 115: 1029–1034.
40. Meeker JD, Calafat AM, Hauser R (2010) Urinary bisphenol A concentrations in relation to serum
thyroid and reproductive hormone levels in men from an infertility clinic. Environ Sci Technol 44: 1458–
1463.
41. Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, et al. (2002) Thyroid hormone action is disrupted
by bisphenol A as an antagonist. J Clin Endocrinol Metab 87: 5185–5190.
42. Matsuda S, Matsuzawa D, Ishii D, Tomizawa H, Sutoh C, et al. (2012) Effects of perinatal exposure to
low dose of bisphenol A on anxiety like behavior and dopamine metabolites in brain. Prog
Neuropsychopharmacol Biol Psychiatry 39: 273–279.
43. Tanida T, Warita K, Ishihara K, Fukui S, Mitsuhashi T, et al. (2009) Fetal and neonatal exposure to
three typical environmental chemicals with different mechanisms of action: mixed exposure to phenol,
phthalate, and dioxin cancels the effects of sole exposure on mouse midbrain dopaminergic nuclei.
Toxicol Lett 189: 40–47.
44. Genro JP, Kieling C, Rohde LA, Hutz MH (2010) Attention-deficit/hyperactivity disorder and the
dopaminergic hypotheses. Expert Rev Neurother 10: 587–601.
Prenatal Phthalates and Child IQ
PLOS ONE | DOI:10.1371/journal.pone.0114003 December 10, 2014 15 / 15
